A randomized, controlled trial of catheter-related infectious event rates using antibiotic-impregnated catheters versus conventional catheters in pediatric cardiovascular surgery patients

Journal of the Pediatric Infectious Diseases Society

Volumn 2, Issue 1, 2013, Pages 67-70

  Cox, Elaine G ^a   Knoderer, Chad A ^a,b   Jennings, Aimee ^c   Brown, John W ^d   Rodefeld, Mark D ^d   Walker, Scott G ^a   Turrentine, Mark W ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BUTLER UNIVERSITY   (United States)

^c Department of Nursing ^*  (United States)

^d Division of Cardio Thoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CLINDAMYCIN; MINOCYCLINE; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ARTICLE; BLEEDING; CARDIOVASCULAR INFECTION; CARDIOVASCULAR SURGERY; CATHETER COMPLICATION; CATHETER DISPLACEMENT; CATHETER INFECTION; CATHETER LEAK; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; DRUG IMPREGNATED CATHETER; FEMALE; HEMATOTHORAX; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VEIN THROMBOSIS;

EID: 84937890098     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis066     Document Type: Article

References (11)

1. Jonge RCJ, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005; 6:329-39.
2. Costello JM, Graham DA, Morrow DF, et al. Risk factors for central line-associated bloodstream infection in a pediatric cardiac intensive care unit. Pediatr Crit Care Med. 2009; 10:453-9.
3. Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
4. Berneholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-20.
5. Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line-associated bloodstream infections: 3 year results. Pediatrics 2011; 128:e1077-83.
6. Schuerer DJE, Zack JE, Thomas J, et al. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. Surg Infect 2007; 8:445-54.
7. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. NEJM 1999; 340:1-8.
8. Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 1997; 127:267-74.
9. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002; 34:1232-42.
10. McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated catheters prevent catheterrelated bloodstream infection? Clin Infect Dis 2003; 37:65-72.
11. Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007; 26:816-20.